Diagnostic Assessment Techniques

Part 1 Pen and Paper in Tremor Evaluation: Clinical Observation Made Simple A pen and paper remain some of the most effective and low-cost tools in assessing tremor type and behavior. Writing tasks and drawing exercises, such as Archimedes spirals, line tracing, and handwriting samples, provide immediate visual feedback that helps clinicians differentiate between essential, dystonic, parkinsonian, and functional tremors. Each tremor type displays its own signature pattern—Essential Tremor: regular, rhythmic oscillations ·       Parkinson’s Disease: small, slow movements with micrographia ·       Dystonic Tremor: jerky, multidirectional movements ·       Functional Tremor: variable and inconsistent presentation Documenting these patterns not only aids in diagnostic accuracy but also creates a valuable baseline for tracking changes over time or in response to treatment. When combined with neurophysiologic and imaging studies, this simple bedside assessment becomes a powerful component of a comprehensive tremor evaluation protocol. Key Points Three simple tasks—handwriting, Archimedes spirals, and line drawing— are quick to perform, provide objective evidence of neurological signs, and assist in tremor differentiation. Essential Tremor vs. Dystonic Tremor: Essential: higher frequency, smaller amplitude, symmetrical, single axis Dystonic: lower frequency, jerky, asymmetric, multidirectional axis, often with increased pen pressure Parkinsonian Tremor: Writing and drawing are smaller, slower, and tightly packed, often showing a unidirectional asymmetric tremor. Functional Tremor: Shows marked variability between and within tasks—an important diagnostic clue. Clinical Use: Handwriting, spiral, and line tasks are ideal for monitoring tremor progression or response to therapy over time.

After diagnosing over 1,000 dementia cases, I've developed a system that primary care doctors can use. You don't need a neuropsychologist. You don't need a 6-month wait for specialty referral. You don't need advanced imaging. Here's my clinical approach: The 15-minute assessment that catches what traditional tests miss: 1/ History from an observer is more valuable than history from the patient ↳ Spouse or adult child notices changes first ↳ Patient often minimizes or doesn't recognize deficits ↳ Ask: "What activities have they stopped doing?" 2/ Digital cognitive testing reveals patterns traditional tests miss ↳ Standardized digital tests eliminate administrator bias ↳ Normative data adjusted for age and education ↳ Qualifies for CPT 96132 reimbursement 3/ The questions that reveal more than any test ↳ "Do you still handle finances independently?" ↳ "Have you gotten lost in familiar places?" ↳ "Are you repeating questions or stories?" ↳ "Have family members expressed concern?" The diagnostic framework I use: Rule out dementia imitators first ↳ Sleep apnea ↳ B12 deficiency ↳ Depression ↳ Medication side effects ↳ Thyroid dysfunction ↳ Hearing loss Establish pattern of decline ↳ Slow and steady suggests neurodegenerative process ↳ Stepwise progression points to vascular dementia ↳ Fluctuating symptoms may indicate Lewy body dementia Assess functional impact ↳ Mild: Independent with complex tasks becoming difficult ↳ Moderate: Needs help with some daily activities ↳ Severe: Requires supervision for safety The diagnosis conversation I have: "Based on everything we've reviewed together, I believe you have early-stage dementia. This means your brain has changes affecting memory and thinking that are beyond normal aging. Here's what we can do about it." Then I create an immediate care plan: Start medications that work better early ↳ Acetylcholinesterase inhibitors add quality years ↳ Side effects minimal if started properly ↳ Benefits appear over years, not days ↳ Earlier start means better outcomes Address modifiable risk factors ↳ Treat cardiovascular disease aggressively ↳ Optimize diabetes control ↳ Manage sleep disorders ↳ Address hearing loss ↳ Encourage physical activity Connect to resources ↳ Alzheimer's Association for education and support ↳ Adult day programs for socialization ↳ Caregiver support groups Specialists are overwhelmed with complex cases ↳ 6-12 month wait times when most cases are straightforward PCPs have longitudinal relationships and know patients best The tools now exist to make this practical ↳ Digital testing is standardized and billable ↳ Care planning has CPT code 99483 The barrier isn't knowledge or skill. It's believing that dementia diagnosis belongs in primary care. It does. with the right support. ⁉️ Primary care providers: what stops you from diagnosing dementia in your practice? 👉 Follow me (Reza Hosseini Ghomi, MD, MSE) for practical dementia care strategies

The Cognitive Disabilities Model (CDM) is a framework developed by Claudia Allen that links cognitive ability to functional performance, using 6 hierarchical cognitive levels to describe a person's capacity for information processing & task performance. It is my favorite model to use & teach, due to its utility with regard to predictive validity & alignment with other more comprehensive conceptual models, such as Kielhofner’s Model of Human Occupation (MOHO), Baum & Christiansen’s Person, Environment, Occupation, Performance (PEOP) model , the OTPF-4 & the ICF. Therapists can use the Allen levels to understand patients’ abilities, & design interventions, environments, & activities to match their functional cognition, promoting success & quality of life.. 6 Cognitive Levels: Each level represents a cumulative skill set. Higher levels indicate increasing functional cognition & independence: Level 1: Automatic Actions— Characterized by automatic responses to stimuli. Total care required. Level 2: Postural Actions— Individuals can move & respond to comfort or discomfort cues but remain largely unaware of their actions' effects on the environment. Level 3: Manual Actions— People learn by habituation & use tools but need set up & supervision for daily activities to ensure safety & proper use. Level 4: Goal-Directed Activity— Patients can perform familiar goal-oriented tasks & scan the environment. All new learning must be taught 1:1. At Allen level 4.6, a person can be left unsupervised for 24 hours. Level 5: Exploratory Actions— People can learn by trial & error, follow written instructions, & drive. They inconsistently understand the impact of their actions but have difficulties planning & reasoning. Level 6: Planned Actions— Represents the highest level of cognitive function. Individuals are fully capable of planning, anticipating, & carrying out tasks independently. How the CDM is Used: Assessment: The Allen Cognitive Level Screen (ACLS) can be used as quick screen to assess a person's sensorimotor skills by observing their ability to perform leather lacing stitches. Other CDM-based assessment tools include the Allen Diagnostic Module, the Routine Task Inventory, & the Cognitive Performance Test, all of which yield Allen performance levels & modes as scores. Intervention: Therapists use assessment results to design appropriate activities, modify the environment, & establish routines to support an individual's best ability to function. Goal-Setting: Healthcare professionals use CDM tools via observation to assess functional cognition & ability to perform tasks, helping to determine a specific cognitive level for tailored care, fostering engagement & success. Support: The model helps to reduce stress & burnout for caregivers by providing a clear framework for understanding & supporting people with cognitive disabilities, enhancing their overall quality of life. Attached is a case study I created to illustrate CDM reasoning.

How to Use Immunohistochemistry (IHC) for Disease Diagnosis and Pathology Research Immunohistochemistry (IHC) is an important tool in disease diagnosis and pathology research that allows visualization of specific proteins in tissue samples. This technique provides insight into disease mechanisms, helps improve diagnostic accuracy, and guides treatment plans. The following is a step-by-step guide to using IHC in these situations: 1. Tissue preparation Tissue samples are obtained from biopsies or surgical specimens and fixed in formalin to preserve cellular structure and proteins. Tissues are embedded in paraffin and cut into thin sections (3-5 µm) for mounting on microscope slides. 2. Dewaxing and antigen retrieval Paraffin is removed with xylene and sections are rehydrated through a graded series of ethanol. Antigen retrieval is performed using heat-induced epitope retrieval (HIER) or enzymatic digestion to restore antibody binding sites. 3. Blocking If an enzyme-based assay is used, endogenous peroxidase activity is blocked using hydrogen peroxide. Blocking buffers (e.g., serum or BSA) are used to reduce nonspecific binding and background staining. 4. Primary Antibody Incubation Incubate tissue with primary antibodies against disease-associated proteins (e.g., HER2 for breast cancer, amyloid-β for Alzheimer's disease). Optimize incubation time and temperature to achieve strong, specific staining. 5. Secondary Antibodies and Detection Add secondary antibodies conjugated to enzymes (e.g., HRP) or fluorophores. Develop with DAB (brown) or visualize using fluorescence microscopy. 6. Counterstaining and Imaging Counterstained with hematoxylin to distinguish nuclei and tissue architecture. Visualize protein expression under light or fluorescence microscopy to identify disease-specific markers. 7. Applications in Diagnosis and Pathology (1) Cancer Diagnosis: Cancer classification and prognosis can be determined by detecting biomarkers such as HER2, Ki-67, or p53. (2) Infectious Disease Diagnosis: Pathogens can be identified using antibodies against microbial antigens. (3) Neurodegenerative Disease Diagnosis: Neurodegenerative diseases can be diagnosed by visualizing proteins such as tau or amyloid-β. In conclusion, IHC can effectively improve the accuracy of disease diagnosis, thereby providing valuable insights into disease characteristics and progression. References [1] So-Woon Kim et al., Journal of Pathology and Translational Medicine 2014 (doi: 10.4132/jptm.2016.08.08) [2] Di Ai et al., Modern Pathology 2020 (DOI: 10.1038/s41379-020-00692-8) #IHC #DiseaseDiagnosis #Pathology #BiomedicalResearch #CancerBiomarkers #Immunohistochemistry #MolecularBiology #PrecisionMedicine

One sample- 15+ techniques. But which one gives the RIGHT answer? In industries like coatings, pharma, and materials science- 👉 Choosing the right characterization technique is everything. 🔬 Major Characterization Techniques (Simplified) 🧪 Structural & Surface Analysis • XRD → Identifies crystal structure & phases • SEM → Surface morphology & defects • AFM → Nanoscale roughness & surface profile 🧬 Chemical Identification • FTIR → Functional groups, binders, degradation • Raman → Pigments, carbon structures • XPS → Surface chemistry & contamination 🎨 Optical & Surface Properties • Spectrophotometer → Color measurement & ΔE • Gloss Meter → Surface reflectance & finish ⚛ Elemental Analysis • AAS → Heavy metals (Pb, Cd, Hg) • ICP-OES → Multi-element detection • XRF → Rapid elemental screening 🔥 Thermal Analysis • TGA → Weight loss, filler content, stability • DSC → Glass transition, curing behavior 🧩 Molecular & Separation Techniques • GPC/SEC → Polymer molecular weight • HPLC → Non-volatile compound separation • GC / GC-MS → Volatile compounds & residual solvents 🧠 Practical Insight 👉 No single technique gives the full picture 👉 Real understanding comes from combining techniques Example: A coating defect investigation may need: ✔ SEM (surface issue) ✔ FTIR (chemical change) ✔ TGA (composition variation) 🎯 Key Takeaway In analytical science: 👉 Right technique = Right decision 👉 Multiple techniques = Complete understanding.